A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

NCT07228247 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors, Adult

Interventions

DRUG: HMPL-A251
DRUG: HMPL-A251

Sponsor

Hutchmed